Detalhe da pesquisa
1.
Cytosolic DNA initiates a vicious circle of aging-related endothelial inflammation and mitochondrial dysfunction via STING: the inhibitory effect of Cilostazol.
Acta Pharmacol Sin
; 2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38689095
2.
Inhibition of miR-214-3p attenuates ferroptosis in myocardial infarction via regulating ME2.
Biochem Biophys Res Commun
; 661: 64-74, 2023 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37087800
3.
SZC-6, a small-molecule activator of SIRT3, attenuates cardiac hypertrophy in mice.
Acta Pharmacol Sin
; 44(3): 546-560, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36042291
4.
Regulation of toll-like receptor (TLR) signaling pathways in atherosclerosis: from mechanisms to targeted therapeutics.
Acta Pharmacol Sin
; 44(12): 2358-2375, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37550526
5.
JMJD6 protects against isoproterenol-induced cardiac hypertrophy via inhibition of NF-κB activation by demethylating R149 of the p65 subunit.
Acta Pharmacol Sin
; 44(9): 1777-1789, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37186122
6.
The m6A demethylase FTO promotes the osteogenesis of mesenchymal stem cells by downregulating PPARG.
Acta Pharmacol Sin
; 43(5): 1311-1323, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-34462564
7.
The novel STAT3 inhibitor WZ-2-033 causes regression of human triple-negative breast cancer and gastric cancer xenografts.
Acta Pharmacol Sin
; 43(4): 1013-1023, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34267347
8.
The novel indomethacin derivative CZ-212-3 exerts antitumor effects on castration-resistant prostate cancer by degrading androgen receptor and its variants.
Acta Pharmacol Sin
; 43(4): 1024-1032, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34321613
9.
Diagnostic value of ultrasound and contrast-enhanced ultrasound in septic acute kidney injury.
J Clin Ultrasound
; 50(4): 505-514, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-34965309
10.
MicroRNA-214 contributes to Ang II-induced cardiac hypertrophy by targeting SIRT3 to provoke mitochondrial malfunction.
Acta Pharmacol Sin
; 42(9): 1422-1436, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33247214
11.
Angiopoietin-2 induces angiogenesis via exosomes in human hepatocellular carcinoma.
Cell Commun Signal
; 18(1): 46, 2020 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32183816
12.
Pharmacological and cardiovascular perspectives on the treatment of COVID-19 with chloroquine derivatives.
Acta Pharmacol Sin
; 41(11): 1377-1386, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32968208
13.
sFRP1 protects H9c2 cardiac myoblasts from doxorubicin-induced apoptosis by inhibiting the Wnt/PCP-JNK pathway.
Acta Pharmacol Sin
; 41(9): 1150-1157, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32238888
14.
PARP1 interacts with HMGB1 and promotes its nuclear export in pathological myocardial hypertrophy.
Acta Pharmacol Sin
; 40(5): 589-598, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30030529
15.
Histone methyltransferase NSD2 mediates the survival and invasion of triple-negative breast cancer cells via stimulating ADAM9-EGFR-AKT signaling.
Acta Pharmacol Sin
; 40(8): 1067-1075, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30670815
16.
Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics.
Acta Pharmacol Sin
; 39(5): 802-824, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29698387
17.
G3BP2 is involved in isoproterenol-induced cardiac hypertrophy through activating the NF-κB signaling pathway.
Acta Pharmacol Sin
; 39(2): 184-194, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28816235
18.
mTORC2 facilitates endothelial cell senescence by suppressing Nrf2 expression via the Akt/GSK-3ß/C/EBPα signaling pathway.
Acta Pharmacol Sin
; 39(12): 1837-1846, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-29991711
19.
Ulinastatin attenuates LPS-induced inflammation in mouse macrophage RAW264.7 cells by inhibiting the JNK/NF-κB signaling pathway and activating the PI3K/Akt/Nrf2 pathway.
Acta Pharmacol Sin
; 39(8): 1294-1304, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29323338
20.
C33(S), a novel PDE9A inhibitor, protects against rat cardiac hypertrophy through upregulating cGMP signaling.
Acta Pharmacol Sin
; 38(9): 1257-1268, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28649129